Literature DB >> 1712547

The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis.

S S Wu1, K Brady, J J Anderson, R Vezina, M Skinner, R S Neiman, B C Wolf.   

Abstract

The authors previously demonstrated that bone marrow plasmacytosis in primary (AL) amyloidosis may be monoclonal or polyclonal. However, the clinical implications of the degree of plasmacytosis and its clonality have not been studied. The authors evaluated 62 patients with AL amyloidosis, 40 of whom had monoclonal medullary plasma cells. There was complete concordance between the light chain class of the plasma cells in the monoclonal cases and that of the circulating paraprotein in the 22 cases associated with a paraprotein. The remaining 22 patients had polyclonal plasma cells, although a paraprotein was detected in 6. The degree of plasmacytosis was significantly higher among patients with monoclonal plasma cells and correlated inversely with length of survival. The authors' findings indicate that the quantitation of bone marrow plasma cells in AL amyloidosis by immunoperoxidase studies may predict the clinical course.

Entities:  

Mesh:

Year:  1991        PMID: 1712547     DOI: 10.1093/ajcp/96.1.95

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

Review 1.  Bone marrow immunohistology of plasma cell neoplasms.

Authors:  A Wei; S Juneja
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Extensive amyloid deposit in bone marrow aspirate.

Authors:  Arvind Ahuja; Pawni Prabhat; Archana Rastogi; Dipanjan Panda; Chandan K Kumar; Shiv Kumar Sarin
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-01       Impact factor: 0.900

Review 3.  Deposition-associated diseases related with a monoclonal compound.

Authors:  M J Molina-Garrido; C Guillén-Ponce; A Mora; M Guirado-Risueño; M A Molina; M J Molina; A Carrato
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

Review 4.  Primary systemic amyloidosis.

Authors:  Morie A Gertz; S Vincent Rajkumar
Journal:  Curr Treat Options Oncol       Date:  2002-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.